RecruitingNCT07407959
Screening and Staging of Benign vs Malignant Pelvic Abnormalities
Clinical Evidence Generation of AI Enabled Fast, Accurate and Precise Screening and Staging of Benign vs Malignant Pelvic Abnormalities
Sponsor
Mayo Clinic
Enrollment
60 participants
Start Date
Sep 4, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates whether newly developed non-FDA approved image processing techniques \[Adaptive Image Reconstruction (AIR Recon) Deep Learning (DL) and Sonic DL\] can provide improved quality and decreased time compared to current scanning techniques.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patient over the age of 18
- For prostate group, any patient referred for prostate MR for screening purposes with no prior prostate related treatment or prior biopsy
- For endometriosis group, any patient referred for possible endometriosis evaluation (pre-surgical)
Exclusion Criteria3
- Individuals unable to undergo MRI imaging (MR-conditional or MR-nonconditional devices which would need additional procedures/conditions for scanning, pregnant people, individuals with implanted metal, etc.)
- Patient under the age of 18
- Patient who is unable to consent
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07407959
Related Trials
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT0699589836 locations
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
NCT048575021 location
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
NCT047882771 location
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
NCT060672952 locations
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
NCT071640271 location